...
首页> 外文期刊>Lupus >Angiogenic activity in sera of patients with systemic lupus erythematosus.
【24h】

Angiogenic activity in sera of patients with systemic lupus erythematosus.

机译:系统性红斑狼疮患者血清中的血管生成活性。

获取原文
获取原文并翻译 | 示例

摘要

Angiogenesis plays a critical role in the pathogenesis of several connective tissue diseases. There is, however, relatively little information available on the role of angiogenesis in systemic lupus erythematosus (SLE). The aim of this study was to investigate the angiogenic activity in sera of patients with SLE and to determine the association between angiogenic activity and clinical complications. Sera from 66 Tunisian females with SLE and from 32 healthy blood donors were studied for their angiogenic activity using the in-vitro tube formation test on Matrigel. Samples were divided into five groups according to their angiogenic activity, which was scored from 0 (no angiogenesis) to 4 (high angiogenic activity). Samples from each group were then tested randomly to assess serum concentration of vascular endothelial growth factor (VEGF). No correlation was found between angiogenic activity scores and serum VEGF levels. Considering angiogenesis assessment in-vitro, sera of patients with SLE showed a much higher angiogenic activity than healthy controls since a high angiogenic score (score 4) is present in 43.9% of patients and in 6.3% of controls (P < 0.0002). This high angiogenic activity is not correlated with disease activity; however, SLE patients with anti-dsDNA antibodies and those with nephritis showed higher angiogenic activity compared with patients without these complications since score 4 is found in 50.9% and 67.9% versus 9.1% (P = 0.017) and 26.3% (P < 0.001), respectively. In conclusion, our study showed that high serum angiogenic activity in SLE was not correlated with the VEGF levels. We suggest the use of the 'in-vitro' tube formation test as a better tool to study the angiogenic potential of sera. We found that in patients with SLE, serum angiogenic activity is increased compared with healthy controls. This high angiogenic activity is associated with renal complications and with the presence of anti-dsDNA antibodies. These findings suggest an involvement of angiogenesis disturbance in the pathogenesis of SLE.
机译:血管生成在几种结缔组织疾病的发病机理中起关键作用。但是,关于血管生成在系统性红斑狼疮(SLE)中的作用的信息相对较少。这项研究的目的是调查SLE患者血清中的血管生成活性,并确定血管生成活性与临床并发症之间的关系。使用在Matrigel上进行的体外管形成测试,研究了66位突尼斯女性SLE患者和32位健康献血者血清的血管生成活性。根据其血管生成活性将样品分为五组,其得分从0(无血管生成)到4(高血管生成活性)。然后随机测试每组的样品,以评估血清血管内皮生长因子(VEGF)的浓度。在血管生成活性评分与血清VEGF水平之间未发现相关性。考虑到体外血管生成评估,SLE患者的血清显示出比健康对照更高的血管生成活性,因为在43.9%的患者和6.3%的对照中存在较高的血管生成评分(评分4)(P <0.0002)。这种高的血管生成活性与疾病活动无关。然而,与没有这些并发症的患者相比,具有抗dsDNA抗体的SLE患者和患有肾炎的患者显示出更高的血管生成活性,因为发现4分分别为50.9%和67.9%,而9.1%(P = 0.017)和26.3%(P <0.001) , 分别。总之,我们的研究表明,SLE的高血清血管生成活性与VEGF水平无关。我们建议使用“体外”管形成测试作为研究血清血管生成潜力的更好工具。我们发现与健康对照组相比,SLE患者的血清血管生成活性增加。这种高血管生成活性与肾脏并发症和抗dsDNA抗体的存在有关。这些发现提示血管生成障碍与SLE的发病机制有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号